Profit Or Loss [Abstract]

Sopharma AD - Filing #6022429

Concept	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31
Profit or loss [abstract]
Profit (loss) [abstract]
Revenue	—	1 663 016 BGN	—	—	—	—	1 603 310 BGN	—
Decrease (increase) in inventories of finished goods and work in progress	—	9 713 BGN	—	—	—	—	8 721 BGN	—
Raw materials and consumables used	—	99 129 BGN	—	—	—	—	83 122 BGN	—
Employee benefits expense	—	147 829 BGN	—	—	—	—	150 061 BGN	—
Depreciation and amortisation expense	—	52 099 BGN	—	—	—	—	53 187 BGN	—
Profit (loss) from operating activities	—	87 881 BGN	—	—	—	—	63 519 BGN	—
Finance income	—	3 304 BGN	—	—	—	—	6 632 BGN	—
Finance costs	—	9 417 BGN	—	—	—	—	11 797 BGN	—
Share of profit (loss) of associates and joint ventures accounted for using equity method	—	22 635 BGN	—	—	—	—	12 092 BGN	—
Profit (loss) before tax	—	85 076 BGN	—	—	—	—	97 574 BGN	—
Tax expense (income)	—	8 743 BGN	—	—	—	—	5 871 BGN	—
Profit (loss)	71 121 BGN	76 333 BGN	71 121 BGN	5 212 BGN	2 207 BGN	89 496 BGN	91 703 BGN	89 496 BGN
Profit (loss), attributable to [abstract]
Profit (loss), attributable to owners of parent	—	71 121 BGN	—	—	—	—	89 496 BGN	—
Profit (loss), attributable to non-controlling interests	—	5 212 BGN	—	—	—	—	2 207 BGN	—
Earnings per share [text block]	—		—	—	—	—	—	—
Earnings per share [abstract]
Earnings per share [line items]
Basic earnings per share [abstract]
Basic earnings (loss) per share	—	0.5900	—	—	—	—	0.7100	—
Diluted earnings per share [abstract]
Diluted earnings (loss) per share	—	0.5700	—	—	—	—	0.7100	—